[II. Molecular targeting therapy for head and neck cancer].
Division of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Makoto
M
Tahara
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D058990:Molecular Targeted Therapy; D027383:Papillomaviridae; D011379:Prognosis; D012008:Recurrence
D000970:Antineoplastic Agents